![Erin Willert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erin Willert
No más puestos en curso
Historial de carrera de Erin Willert
Antiguos cargos conocidos de Erin Willert.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MOLECULAR TEMPLATES, INC. | Director Técnico/Científico/I+D | - | - |
Molecular Templates, Inc. /Old/
![]() Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Director Técnico/Científico/I+D | 09/10/2013 | - |
Formación de Erin Willert.
The University of Texas Southwestern Medical Center | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Molecular Templates, Inc. /Old/
![]() Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Erin Willert
- Experiencia